Cytarabine Coupons & Discount Card – Guaranteed Prices from $8.65
My prescription
Edit
25ML of 20MG/ML, Cytarabine (1 Vial)
Select pharmacy
Walgreens
$8.65
COUPON PRICECytarabine savings card
Show this card to your pharmacistWalgreens
$8.65
BIN
ID
PCN
GRP
019876
LHC13D3BBD
CHIPPO
LHX
Powered by
Related nucleoside metabolic inhibitors prescriptions
Related nucleoside metabolic inhibitors prescriptions
Cytarabine dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 25ML of 20MG/ML | 1 Vial | $8.65 | $8.65 |
Cytarabine Warnings
This medication can affect bone marrow function, leading to decreased levels of blood cells, including red cells, white cells, and platelets. Such effects may result in anemia, a reduced ability to combat infections, or increased susceptibility to bruising and bleeding. Notify your healthcare provider immediately if you experience symptoms like unusual tiredness, pale skin, persistent sore throat, fever, chills, or easy bruising/bleeding.
Low Blood Cell Counts: Cytarabine often causes decreased blood cell counts, which can result in fatigue, increased bleeding risk, and greater susceptibility to serious infections. Regular blood cell count monitoring by your oncologist is essential. Adjustments to your treatment may be necessary if counts are low. To minimize infection risk, practice good hygiene, avoid crowded places, and monitor your temperature. Contact your provider if your temperature reaches 100.4°F or higher.
Nervous System Issues: High doses of cytarabine may lead to nervous system complications, including loss of coordination, balance difficulties, and speech problems. These issues are rare with lower doses. Your oncology team will monitor these functions to ensure the medication remains safe for you.
Gastrointestinal Concerns: High doses of cytarabine have been linked to severe stomach problems such as ulcers and inflammation. Report any stomach pain, nausea, vomiting, or swelling to your oncologist promptly.
Ocular Complications: Cytarabine can affect the eyes, causing corneal damage and conjunctival bleeding, particularly at high doses. Preventative measures, like corticosteroid eye drops, may be recommended by your doctor.
Cardiac Issues: High doses of cytarabine may cause serious heart problems, including chest pain, cardiomyopathy, and pericarditis. Seek immediate medical attention if you experience chest pain, irregular heartbeat, or breathing difficulties.
Respiratory Problems: Serious lung issues are possible with cytarabine, especially at high doses. Report any breathing difficulties, persistent cough, or fatigue to your oncologist without delay.
Pregnancy Risks: Cytarabine might harm an unborn child, particularly during the first trimester. Inform your oncologist immediately if you become pregnant while on this medication.
Tumor Lysis Syndrome: This condition can occur when cancer cells break down rapidly during treatment, potentially leading to serious complications. Your oncology team will monitor you closely and may prescribe medications to prevent this syndrome.
Please consult your healthcare provider for further guidance and any questions regarding the use of cytarabine.
Cytarabine Side Effects
Common side effects:
- nausea
- vomiting
- diarrhea
- loss of appetite
- mouth sores
- headache
- dizziness
- temporary hair loss
Less common but important to monitor:
- liver problems
- muscle and bone pain
- chest pain
- shortness of breath
- vision changes
- difficulty swallowing
- anal sores
- kidney issues
- joint or back pain
- numbness in extremities
- unusual bleeding or bruising
Serious side effects:
- low blood cell counts
- heart or lung problems
- Cytarabine syndrome
- serious allergic reaction
Cytarabine Interactions
Interactions with high risk of serious adverse effects and should be avoided:
- Measles Virus Vaccine, Live
- Mumps Virus Vaccine, Live
- Rotavirus Vaccine, Live
- Rubella Virus Vaccine, Live
- Varicella Virus Vaccine, Live
- Zoster Vaccine, Live
Interactions with moderate risk that may require dose adjustment, closer monitoring, or timing changes:
- Adenovirus Vaccine
- Bacillus of Calmette and Guerin Vaccine, Live
- Cedazuridine
- Cholera Vaccine, Live
- Dengue Tetravalent Vaccine, Live
- Influenza Virus Vaccine, Live
- Poliovirus Vaccine, Live
- Smallpox Vaccine
- Typhoid Vaccine, Live
- Yellow Fever Vaccine
Interactions with low risk that usually do not require a change in therapy:
- Digoxin
- Flucytosine
- gentamicin
What type of chemotherapy is cytarabine?
Cytarabine is an antimetabolite chemotherapy drug. It works by interfering with the DNA synthesis of cancer cells, which inhibits their growth and leads to cell death. It is commonly used in the treatment of certain types of leukemia and lymphoma.
What is the main toxic effect of cytarabine?
The main toxic effect of cytarabine is myelosuppression, which can lead to decreased production of blood cells, resulting in conditions such as anemia, leukopenia, and thrombocytopenia. This can increase the risk of infections, fatigue, and bleeding.
Do you lose your hair with cytarabine?
Hair loss can be a side effect of cytarabine, although it does not occur in everyone. The extent of hair loss can vary from person to person. If hair loss occurs, it is usually temporary, and hair typically grows back after the treatment is completed. It is important for patients to discuss any concerns about side effects with their healthcare provider.
What does cytarabine do to the body?
Cytarabine is a chemotherapy medication that primarily affects rapidly dividing cells. It works by interfering with DNA synthesis, which is crucial for cell replication. This action makes it effective in treating certain types of cancer, particularly leukemias. However, because it targets rapidly dividing cells, it can also affect normal cells that divide quickly, such as those in the bone marrow, gastrointestinal tract, and hair follicles, leading to potential side effects like bone marrow suppression, nausea, and hair loss.
What toxicity is most likely to occur in patients who are receiving a regimen including cytarabine and daunorubicin?
Patients receiving a regimen that includes cytarabine and daunorubicin are most likely to experience myelosuppression as a toxicity. This condition involves the suppression of bone marrow activity, leading to decreased production of blood cells, which can result in anemia, increased risk of infection, and bleeding tendencies.